Burke J. Brooks

2.3k total citations · 1 hit paper
24 papers, 1.7k citations indexed

About

Burke J. Brooks is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Burke J. Brooks has authored 24 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 7 papers in Epidemiology. Recurrent topics in Burke J. Brooks's work include Lung Cancer Research Studies (12 papers), Lung Cancer Treatments and Mutations (9 papers) and Neuroendocrine Tumor Research Advances (6 papers). Burke J. Brooks is often cited by papers focused on Lung Cancer Research Studies (12 papers), Lung Cancer Treatments and Mutations (9 papers) and Neuroendocrine Tumor Research Advances (6 papers). Burke J. Brooks collaborates with scholars based in United States and Canada. Burke J. Brooks's co-authors include Marion M. Nau, Edward A. Sausville, Adi F. Gazdar, James F. Battey, John D. Minna, Gregory Hollis, Ilan R. Kirsch, O. Wesley McBride, Virginia Bertness and J D Minna and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Burke J. Brooks

24 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer

1985 543 citations Marion M. Nau, Burke J. Brooks et al. Nature profile →

Peers

Countries citing papers authored by Burke J. Brooks

Since Specialization

Citations

This map shows the geographic impact of Burke J. Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burke J. Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burke J. Brooks more than expected).

Fields of papers citing papers by Burke J. Brooks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Burke J. Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burke J. Brooks. The network helps show where Burke J. Brooks may publish in the future.

Co-authorship network of co-authors of Burke J. Brooks

This figure shows the co-authorship network connecting the top 25 collaborators of Burke J. Brooks. A scholar is included among the top collaborators of Burke J. Brooks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Burke J. Brooks. Burke J. Brooks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Results of combined‐modality therapy for limited‐stage small cell lung carcinoma in the elderly 2005 ·Cancer ·Steven E. Schild, Philip J. Stella, Burke J. Brooks, Sumithra J. Mandrekar, James A. Bonner, William L. McGinnis, James A. Mailliard, James E. Krook, Richard L. Deming, Alex A. Adjei, Aminah Jatoi, James R. Jett	54
2	Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer 2004 ·International Journal of Radiation OncologyBiologyPhysics ·Steven E. Schild, James A. Bonner, Thomas G. Shanahan, Burke J. Brooks, Randolph S. Marks, Susan M. Geyer, Shauna L. Hillman, Gist H. Farr, Henry D. Tazelaar, James E. Krook, Francois J. Geoffroy, Muhammad Salim, Robert M. Arusell, James A. Mailliard, Paul Schaefer, James R. Jett	114
3	The Results of combined modality therapy for limited stage small cell lung cancer (LD-SCLC) in the elderly 2004 ·Journal of Clinical Oncology ·Steven E. Schild, Philip J. Stella, Burke J. Brooks, Sumithra J. Mandrekar, James A. Bonner, William L. McGinnis, Daniel A. Nikcevich, Alex A. Adjei, Aminah Jatoi, James R. Jett	1
4	A quality-adjusted reanalysis of a Phase III trial comparing once-daily thoracic radiation vs. twice-daily thoracic radiation in patients with limited-stage small-cell lung cancer 2002 ·International Journal of Radiation OncologyBiologyPhysics ·Jeff A. Sloan, James A. Bonner, Shauna L. Hillman, Cristine Allmer, Thomas G. Shanahan, Burke J. Brooks, Randolph S. Marks, Delfino Vargas Chanes, James R. Jett	14
5	A new graphic for quality adjusted life years (Q-TWiST) survival analysis: The Q-TWiST plot 2002 ·Quality of Life Research ·Jeff A. Sloan, Daniel J. Sargent, (unknown), Cristine Allmer, Delfino Vargas Chanes, Edward T. Creagan, James A. Bonner, Michael J. O’Connell, Robert J. Dalton, Kendrith M. Rowland, Burke J. Brooks, John A. Laurie	9
6	Challenges in Oncology 2002 ·Journal of Clinical Oncology ·Burke J. Brooks, (unknown), Christopher D.�M. Fletcher, George D. Demetri	23
7	A Randomized Trial of Postoperative Adjuvant Therapy in Patients with Completely Resected Stage II or IIIa Non–Small-Cell Lung Cancer 2000 ·New England Journal of Medicine ·Steven M. Keller, Sudeshna Adak, Henry Wagner, Arnold Herskovic, Ritsuko Komaki, Burke J. Brooks, Michael C. Perry, Robert B. Livingston, David H. Johnson	300
8	Phase III Comparison of Twice-Daily Split-Course Irradiation Versus Once-Daily Irradiation for Patients With Limited Stage Small-Cell Lung Carcinoma 1999 ·Journal of Clinical Oncology ·James A. Bonner, Jeff A. Sloan, Thomas G. Shanahan, Burke J. Brooks, Randolph S. Marks, James E. Krook, James B. Gerstner, Andrew W. Maksymiuk, Ralph Levitt, James A. Mailliard, Henry D. Tazelaar, Shauna L. Hillman, James R. Jett	150
9	2 Randomized prospective comparison of adjuvant mediastinal radiation (RT) with or without concurrent chemotherapy with cisplatin and etoposide (PE) for patients with completely resected 51-3N1-2M0 non-small cell lung cancer (NSCLC): US 1999 ·International Journal of Radiation OncologyBiologyPhysics ·Stefan M. Keller, S. Adak, (unknown), Arnold Herskovic, Ritsuko Komaki, Burke J. Brooks, (unknown), Robert B. Livingston, David H. Johnson	10
10	Phase II Trial of Topotecan for the Treatment of Mesothelioma 1998 ·American Journal of Clinical Oncology ·Andrew W. Maksymiuk, Robert F. Marschke, Henry D. Tazelaar, (unknown), Suresh Nair, Randolph S. Marks, Burke J. Brooks, James A. Mailliard, Gerardo Burton, James R. Jett	24
11	Phase II trial of carboplatin plus cisplatin in recurrent and advanced squamous cell carcinoma of the head and neck. 1991 ·Journal of Clinical Oncology ·Isaiah W. Dimery, Burke J. Brooks, R Winn, Ting Martin, Mihran Shirinian, Waun Ki Hong	10
12	Delayed Life-Threatening Pneumonitis Secondary to Procarbazine 1990 ·American Journal of Clinical Oncology ·Burke J. Brooks, (unknown), Salvador Álvarez, (unknown), Stephen F. Grinton	10
13	Structure and Expression of the Human L- myc Gene Reveal a Complex Pattern of Alternative mRNA Processing 1988 ·Molecular and Cellular Biology ·Frederic J. Kaye, James F. Battey, Marion M. Nau, Burke J. Brooks, E Seifter, Jacques De Grève, Michael J. Birrer, Edward A. Sausville, John D. Minna	29
14	Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer. 1986 ·Journal of Clinical Oncology ·Burke J. Brooks, E Seifter, Thomas Walsh, Allen S. Lichter, Paul A. Bunn, (unknown), Anita Johnston-Early, Margaret Edison, Robert Makuch, Martin H. Cohen	57
15	Chromosomal deletion, gene amplification, alternative processing, and autocrine growth factor production in the pathogenesis of human lung cancer. 1986 ·PubMed ·John D. Minna, (unknown), M. J. Birrer, Burke J. Brooks, F. Cuttitta, (unknown), Adi F. Gazdar, B. E. Johnson, Marion M. Nau, Edward A. Sausville	2
16	Human small-cell lung cancers show amplification and expression of the N-myc gene. 1986 ·Proceedings of the National Academy of Sciences ·Marion M. Nau, Burke J. Brooks, D N Carney, A F Gazdar, (unknown), Edward A. Sausville, J D Minna	254
17	L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer breakdown → 1985 ·Nature ·Marion M. Nau, Burke J. Brooks, James F. Battey, Edward A. Sausville, Adi F. Gazdar, Ilan R. Kirsch, O. Wesley McBride, Virginia Bertness, Gregory Hollis, John D. Minna	543
18	Serum Inhibitor in Systemic Lupus Erythematosus Associated With Aplastic Anemia 1984 ·Archives of Internal Medicine ·Burke J. Brooks	27
19	Fatal herpetic hepatitis in pregnancy. 1983 ·PubMed ·(unknown), Burke J. Brooks, Fred H. Rodriguez, Henry R. Lesesne, J. Charles Jennette	27
20	Apparent Ketoconazole Failure in Candidal Cholecystitis 1982 ·Archives of Internal Medicine ·Burke J. Brooks	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact